SlimSEB: Haɗin Probiotic da Enzyme Ya Lashe Placebo—Amma Akwai Matsala
Takaitawa: Wani haɗin probiotic, enzyme da ganyen shuke‑shuke da ake kira SlimSEB ya doke placebo a gwajin bazuwar makonni 12 da ya kunshi mutane 87 da ke cikin haɗarin cutar sukari ta nau’i II. Mutanen da suka yi kiba sun rasa kilogram 4.5 fiye da placebo, suka rage da'irar ƙirjinsu da santimita 11, yayin da kolesterol da alamun rashin amincewar insulin ma suka inganta. Sai dai samfurin an samar da shi daga kamfanin da ya ƙirƙira shi, gwajin ƙarami ne kuma gajere, kuma haɗin sinadarai da yawa yana nufin babu wani abu guda ɗaya da za a iya ɗauka a matsayin babban dalilin sakamakon. Ga abin da bayanan suka nuna, yadda yake kwatanta da magungunan GLP‑1, da kuma abin da ya kamata mu yi la’akari da shi sau biyu.
Menene Gwajin Ya Gano Da Gaske?
Takardar da aka wallafa a Frontiers in Nutrition a shekarar 2026 (Rathi et al., DOI 10.3389/fnut.2026.1956865) ta tantance kari mai suna SlimSEB. Wannan haɗin ya ƙunshi:
- Probiotics – 1.5 biliyan CFU
- Enzymes na narkewa, ciki har da SucroSEB – da masana suka ce yana canza sukari na abinci zuwa prebiotic fiber
- Furen mulberry
- Green tea
- Cinnamon (kirfa) da aka niƙa
- Chromium picolinate
Tsarin gwajin ya kasance: gaba‑gaba, bazuwar, biyu‑mai‑shiru, rukuni‑mai‑daidai, tare da placebo a matsayin ma’auni. An ba mutane 87 da ke cikin haɗarin cutar sukari ta nau’i II SlimSEB ko placebo a kowace rana tsawon kwanaki 84 (makonni 12). Daga ciki, 43 an ayyana su a matsayin masu nauyi (BMI ≥ 25) kuma 44 a matsayin masu kiba (BMI ≥ 30). Gwajin ya samu rijista a matsayin CTRI/2023/11/059798.
Sakamakon Da Ya Fi Fice
Idan aka kwatanta da placebo, SlimSEB ya haifar da raguwar da ta zama statistically significant:
- Matsayin nauyi: -2.60 kg a rukuni masu nauyi (p = 0.0045) da -4.51 kg a rukuni masu kiba (p < 0.0001)
- BMI: -0.92 da -1.80 kg/m²
- Da'irar ƙirji: -3.86 cm a masu nauyi (p = 0.0169) da -11.03 cm a masu kiba (p = 0.0014)
Raguwar da'irar ƙirji a rukuni masu kiba – santimita 11 cikin makonni 12 – tana da tasiri sosai, amma dole ne a yi hankali wajen fassara wannan sakamako.
Canjin Alamun Metabolism
Takardar ta kuma nuna ci gaba a alamun sukari a jini:
- Fasting plasma glucose ya sauka 0.45 mmol/L a duka rukunan
- HbA1c ya sauka 0.65 % da 0.67 %
- HOMA‑IR (kimar rashin amincewar insulin) ya sauka 0.47 da 0.69, wato raguwar kashi 21.5 % a masu nauyi da 24.8 % a masu kiba, alhali a placebo raguwar kawai kashi 9.0 % da 4.3 % bi da bi.
Kolesterol ne ya nuna bambanci mafi girma:
- Total cholesterol ya ragu 14.21 % da 16 % da SlimSEB, yayin da a placebo ya ragu 3.85 % a masu nauyi amma ya tashi 8.65 % a masu kiba.
- LDL‑C ya ragu 11.61 % da 14.63 % da SlimSEB, alhali a placebo ya ragu 0.88 % a masu nauyi amma ya tashi 13.39 % a masu kiba.
- C‑reactive protein (CRP), alamar kumburi, ya ragu 13.6 % da 17.3 %, amma bambancin ya kasance ƙarfi ne kawai a rukuni masu kiba.
Lura: a rukuni na placebo, matakan lipids sun tabarbare a cikin masu kiba, wanda ya sa bambancin ya zama mafi girma fiye da yadda raguwar SlimSEB kadai zai nuna.
Tsaro Da Rahusa
An samu abubuwa 8 da suka faru a sauƙaƙe, babu ɗaya da aka danganta da samfurin, kuma ba a sami wani yanayi mai tsanani ba. Wannan alama ce ta kyau, amma gwajin mutane 87 na tsawon makonni 12 ba zai iya gano matsaloli masu tsanani ko na dogon lokaci ba.
Ƙalubale Da Sauran Ƙuntatawa
- Zama tare da masana’anta. SlimSEB an samar da shi daga Specialty Enzymes and Probiotics (USA) – kamfanin da ya ƙirƙira shi. Wannan na iya haifar da gurbata sakamakon, don haka ana bukatar gwaje‑gwajen da masu zaman kansu suka gudanar.
- Samfur ƙanana ne kuma a ƙasa guda. Gwajin ya gudana a Indiya tare da mutum 87 kacal. Saboda haka ba lallai ne sakamakon ya shafi al'ummomi, abinci, ko yanayin rayuwa daban‑daban ba.
- Lokaci gajere. Makonni 12 ba su ba da haske kan ko raguwar nauyi za ta ci gaba da kasancewa ko ko fa’idodin za su dawwama ba.
- Haɗin sinadarai da yawa. Probiotics, enzymes, mulberry, green tea, cinnamon da chromium na ƙunshe a cikin samfur guda; babu wani abu ɗaya da za a iya ɗauka a matsayin babban dalilin tasirin.
- Ba a fayyace ƙimar ba. Ba a bayar da cikakken adadin kowanne sinadari da ake shan kullum ba, don haka ba mu da isasshen bayani don tantance ingancin kowane ɓangare.
Tasirin Raguwar Nauyi – Ta yaya yake kwatantawa?
Raguwar nauyi tsakanin kilogram 2.6 zuwa 4.5 da aka samu bayan cire tasirin placebo ba ta kai matakin magungunan GLP‑1 ba. A gwajin STEP 1, semaglutide ya haifar da raguwar nauyi kusan 15 % na nauyin jiki a tsawon makonni 68. SlimSEB bai kai wannan matakin ba, kuma yanzu ba mu da alamu da ke nuna zai iya maye gurbin waɗannan magunguna. Wataƙila ya zama ƙarin taimako ga waɗanda ke neman rage nauyi a mataki na farko.
Yadda Za a Amfani Da Shi a Rayuwa
Adadin da lokacin amfani: Gwajin ya ba da shawarar shan kari ɗaya a kowace rana tsawon kwanaki 84, amma ba a fayyace girman ƙwayar ba. Abu guda da muka tabbatar da shi shine 1.5 biliyan CFU na probiotic.
Wanda zai amfana: Shaidu sun shafi manya masu nauyi ko masu kiba da ke cikin haɗarin cutar sukari ta nau’i II. Ba su shafi masu cutar sukari ta tsananta, yara, ko masu nauyi kaɗan ba.
Wadanda ya kamata su guje ko su tuntuɓi likita kafin su fara (ba cikakken jerin daga wannan takarda ba):
- Mutanen da ke kan maganin sukari, saboda haɗin da ke iya rage matakan sukari.
- Matan da ke cikin ciki ko masu shayarwa.
- Mutanen da suke da raunin garkuwar jiki – probiotics na rayuwa na bukatar tsaro.
- Wadanda ke da matsalar rashin jure caffeine ko abubuwan da ke cikin green tea.
- Wadanda suke neman ragin nauyi mai tsanani kamar na GLP‑1.
Kammalawa
Sakamakon SlimSEB na da alƙawari, amma har yanzu a matakin farko ne, kuma an samo shi ne daga kamfanin da ya ƙirƙira samfurin. Abincin da ya fi inganci, motsa jiki, da barci na har yanzu su ne tubalan da suka fi tasiri. Gwaje‑gwajen da masu zaman kansu suka gudanar, tare da tsawon lokaci da yawan mahalarta, za su taimaka mana mu tantance ko wannan haɗin ya cancanci a saka shi a matsayin ƙarin hanya ga waɗanda ke neman rage kiba da inganta alamar metabolism.
